BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 33909066)

  • 1. Unusual Localization of Blood-Borne Loa loa Microfilariae in the Skin Depends on Microfilarial Density in the Blood: Implications for Onchocerciasis Diagnosis in Coendemic Areas.
    Niamsi-Emalio Y; Nana-Djeunga HC; Chesnais CB; Pion SDS; Tchatchueng-Mbougua JB; Boussinesq M; Basáñez MG; Kamgno J
    Clin Infect Dis; 2021 Jun; 72(Suppl 3):S158-S164. PubMed ID: 33909066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-infection with Onchocerca volvulus and Loa loa microfilariae in central Cameroon: are these two species interacting?
    Pion SD; Clarke P; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
    Parasitology; 2006 Jun; 132(Pt 6):843-54. PubMed ID: 16469200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating post-treatment Loa loa microfilarial densities to classify serious adverse events caused by ivermectin: a retrospective analysis.
    Boullé C; Chesnais CB; Kamgno J; Gardon J; Chippaux JP; Ranque S; Garcia A; Pion SD; Boussinesq M
    Lancet Microbe; 2023 Feb; 4(2):e93-e101. PubMed ID: 36646105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loa loa Microfilariae in Skin Snips: Consequences for Onchocerciasis Monitoring and Evaluation in L. loa-Endemic Areas.
    Nana-Djeunga HC; Fossuo-Thotchum F; Pion SD; Chesnais CB; Kubofcik J; Mackenzie CD; Klion AD; Boussinesq M; Nutman TB; Kamgno J
    Clin Infect Dis; 2019 Oct; 69(9):1628-1630. PubMed ID: 30861060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection.
    Gardon J; Gardon-Wendel N; Demanga-Ngangue ; Kamgno J; Chippaux JP; Boussinesq M
    Lancet; 1997 Jul; 350(9070):18-22. PubMed ID: 9217715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Co-endemicity of loiasis and onchocerciasis in rain forest communities in southwestern Nigeria.
    Ojurongbe O; Akindele AA; Adeleke MA; Oyedeji MO; Adedokun SA; Ojo JF; Akinleye CA; Bolaji OS; Adefioye OA; Adeyeba OA
    PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003633. PubMed ID: 25812086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and validation of small animal models for onchocerciasis and loiasis microfilaricide discovery.
    Ayiseh RB; Mbah GE; Monya E; Ndi EM; Sakanari J; Lustigman S; Cho-Ngwa F
    PLoS Negl Trop Dis; 2023 Feb; 17(2):e0011135. PubMed ID: 36827447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Utilisation of Rapid Assessment Procedures for Loiasis (RAPLOA) and Onchocerciasis (REA) in Rain forest Villages of Cameroon.
    Wanji S; Tendongfor N; Esum M; Yundze SS; Taylor MJ; Enyong P
    Filaria J; 2005 Apr; 4(1):2. PubMed ID: 15817124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of repeated annual community directed treatment with ivermectin on loiasis parasitological indicators in Cameroon: Implications for onchocerciasis and lymphatic filariasis elimination in areas co-endemic with Loa loa in Africa.
    Wanji S; Chounna Ndongmo WP; Fombad FF; Kengne-Ouafo JA; Njouendou AJ; Longang Tchounkeu YF; Koudou B; Bockarie M; Fobi G; Roungou JB; Enyong PA
    PLoS Negl Trop Dis; 2018 Sep; 12(9):e0006750. PubMed ID: 30226900
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Implications for annual retesting after a test-and-not-treat strategy for onchocerciasis elimination in areas co-endemic with Loa loa infection: an observational cohort study.
    Pion SD; Nana-Djeunga H; Niamsi-Emalio Y; Chesnais CB; Deléglise H; Mackenzie C; Stolk W; Fletcher DA; Klion AD; Nutman TB; Boussinesq M; Kamgno J
    Lancet Infect Dis; 2020 Jan; 20(1):102-109. PubMed ID: 31676244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Test-and-Not-Treat Strategy for Onchocerciasis in Loa loa-Endemic Areas.
    Kamgno J; Pion SD; Chesnais CB; Bakalar MH; D'Ambrosio MV; Mackenzie CD; Nana-Djeunga HC; Gounoue-Kamkumo R; Njitchouang GR; Nwane P; Tchatchueng-Mbouga JB; Wanji S; Stolk WA; Fletcher DA; Klion AD; Nutman TB; Boussinesq M
    N Engl J Med; 2017 Nov; 377(21):2044-2052. PubMed ID: 29116890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of an Onchocerca ochengi microfilarial hamster model for onchocerciasis drug screens.
    Mbah GE; Ayiseh RB; Cho-Ngwa F
    BMC Infect Dis; 2016 Aug; 16(1):404. PubMed ID: 27515037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The temporal relationship between onchocerciasis and epilepsy: a population-based cohort study.
    Chesnais CB; Nana-Djeunga HC; Njamnshi AK; Lenou-Nanga CG; Boullé C; Bissek AZ; Kamgno J; Colebunders R; Boussinesq M
    Lancet Infect Dis; 2018 Nov; 18(11):1278-1286. PubMed ID: 30268645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between skin snip and Ov16 ELISA: Two diagnostic tools for onchocerciasis in a focus in Cameroon after two decades of ivermectin-based preventive chemotherapy.
    Djune-Yemeli L; Domché A; Nana-Djeunga HC; Donfo-Azafack C; Lenou-Nanga CG; Masumbe-Netongo P; Kamgno J
    PLoS Negl Trop Dis; 2022 May; 16(5):e0010380. PubMed ID: 35499993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microfilarial distribution of Loa loa in the human host: population dynamics and epidemiological implications.
    Pion SD; Filipe JA; Kamgno J; Gardon J; Basáñez MG; Boussinesq M
    Parasitology; 2006 Jul; 133(Pt 1):101-9. PubMed ID: 16764737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Secondary effects of the treatment of hypermicrofilaremic loiasis using ivermectin].
    Ducorps M; Gardon-Wendel N; Ranque S; Ndong W; Boussinesq M; Gardon J; Schneider D; Chippaux JP
    Bull Soc Pathol Exot; 1995; 88(3):105-12. PubMed ID: 8555762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and Validation of Loa loa Microfilaria-Specific Biomarkers: a Rational Design Approach Using Proteomics and Novel Immunoassays.
    Drame PM; Meng Z; Bennuru S; Herrick JA; Veenstra TD; Nutman TB
    mBio; 2016 Feb; 7(1):e02132-15. PubMed ID: 26884435
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Filaricidal properties of Lantana camara and Tamarindus indica extracts, and Lantadene A from L. camara against Onchocerca ochengi and Loa loa.
    Ngwewondo A; Wang M; Manfo FPT; Samje M; Ganin's JN; Ndi E; Andersen RJ; Cho-Ngwa F
    PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006565. PubMed ID: 29897908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-endemicity of loiasis and onchocerciasis in the South West Province of Cameroon: implications for mass treatment with ivermectin.
    Esum M; Wanji S; Tendongfor N; Enyong P
    Trans R Soc Trop Med Hyg; 2001; 95(6):673-6. PubMed ID: 11816443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sociodemographics, Clinical Factors, and Biological Factors Associated with Loiasis in Endemic Onchocerciasis Areas in Southern Gabon.
    Moutongo Mouandza R; Mourou JR; Moutombi Ditombi B; Roger Sibi Matotou H; Ekomi B; Bouyou-Akotet MK; Mawili-Mboumba DP
    Am J Trop Med Hyg; 2023 Oct; 109(4):850-857. PubMed ID: 37339766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.